Response to influenza vaccination in lymphoma patients treated with CHOP and rituximab.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections; Non-Hodgkin's lymphoma
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms RITUXIVAC
- 31 Jan 2014 Biomarkers information updated
- 15 Oct 2012 Planned end date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 15 Oct 2012 New source identified and integrated (NCT01707628: ClinicalTrials.gov: US National Institutes of Health).